TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06401928

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: transcranial direct current stimulation
Description: Patients will receive 10 sessions of either 1.5 mA electrical stimulation for 20 minutes each day over 10 consecutive days.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial direct current stimulation combined with cognitive training
Description: Patients will receive 10 sessions of 20 minutes of 1.5 mA electrical stimulation on 10 consecutive days. Each session is followed by 30 minutes cognitive training in which patients conduct several computerized cognitive tests.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: transcranial direct current stimulation
Description: Patients will receive 10 sessions of sham (placebo) electrical stimulation for 20 minutes each day over 10 consecutive days.
Study: NCT06532019

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Targeted intervention based on risk factors
Description: Correct hypoalbuminemia, anemia or hyponatremia, and try to enhance medication to lower NT-proBNP, CRP, NYHA Classification, to add diuretics for patients with higher RADs, multidiscipline intervention for patients complicating COPD, and actively reperfusion for ischemic HFpEF patients.
Study: NCT06024577

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Walking
Description: Prescribed 150 minutes per week of moderate to vigorous walking.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Variety
Description: Prescribed 150 minutes per week of moderate to vigorous variety of exercise. Each week participants are randomly asked to participate in cycling, walking/jogging, yoga/Pilates, or cross-training.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Progressive
Description: Prescribed 150 minutes per week of moderate to vigorous progressive variety of exercise. Each week participants are randomly asked to participate in cycling, walking/jogging, yoga/Pilates, or cross-training. Participants can choose which exercise they want to do, and can do as much or little as they want.
Study: NCT06181643

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Survivorship Sleep Program with Individual Delivery + No Booster Sessions
Description: 4 weekly SSP sessions delivered to individual participants (session durations approximately 45 min/session). No booster sessions.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Survivorship Sleep Program with Group Delivery + No Booster Sessions
Description: 4 weekly SSP sessions delivered to groups of participants (session durations approximately 90 min/session). No booster sessions.
Study: NCT05641376

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nebulized Dexmedetomidine
Description: Children will receive a nebulized dexmedetomidine 2 mic/ kg diluted in 3 ml of 0.9% saline 1 h before induction of anaesthesia by standard hospital jet nebulizer via a mouthpiece with a continuous flow of 100% oxygen at 6 L /min for 10-15 min. Treatment will be stopped when the nebulizer began to sputter. At end of nebulizer administration, they will be observed for 30 min before induction of general anaesthesia. then the children will be transferred to the operation room and will receive intravenous (IV) normal saline 0.9% in 10 ml volume over 10 minutes after anesthesia induction.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous Dexmedetomidine
Description: Children will receive nebulized 3 ml of 0.9% normal saline 1 h before induction of anaesthesia by standard hospital jet nebulizer via a mouthpiece with a continuous flow of 100% oxygen at 6 L /min for 10-15 min. then the children will be transferred to the operation room and will receive intravenous (IV) dexmedetomidine 1mic/kg diluted in 10 ml of 0.9% saline over 10 minutes after anesthesia induction.
Study: NCT06181643

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Survivorship Sleep Program with Individual Delivery + 3 Booster Sessions
Description: 4 weekly SSP sessions delivered to individual participants (session durations approximately 45 min/session). 3 monthly booster sessions.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Survivorship Sleep Program with Group Delivery + 3 Booster Sessions
Description: 4 weekly SSP sessions delivered to groups of participants (session durations approximately 90 min/session). 3 monthly booster sessions.
Study: NCT04861805

Intervention type: DEVICE
Group type: OTHER
Intervention: Vienna Aortic Valve SE System
Description: Vienna Aortic Valve SE system for TAVI.
Study: NCT06500442

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NEU-111
Description: Oral Doses

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral Doses
Study: NCT06111846

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: human Bone Marrow Mesenchymal Stem Cell (hBMMSC)
Description: Group 1: 1.0×10\^6 cells/kg (participant's body weight) single dose (n=3) Group 2: 2.0×10\^6 cells/kg (participant's body weight) single dose (n=3) Group 3: 2.0×10\^6 cells/kg (participant's body weight) administered twice (n=4)
Study: NCT04805021

Intervention type: OTHER
Intervention: no intervention
Description: no intervention

Intervention type: OTHER
Intervention: no intervention
Description: no intervention

Intervention type: OTHER
Intervention: no intervention
Description: no intervention

Intervention type: OTHER
Intervention: no intervention
Description: no intervention
Study: NCT06634901

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Health Literacy Educational Session- Comparator
Description: During the pre-to-post-test interval for the Knowledge, Attitudes, and Practices (KAP) measure, participants in this arm will take a break and have lunch.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health Literacy Educational Session
Description: The Intervention is a 90 minute small group (n=6-10) session with an expert epilepsy provider reviewing fundamental information about epilepsy being a treatable neurologic condition, with topics including epidemiology, causation facts and myths, treatment and the importance of consistent medication, stigma, barriers to care and well-being. These topics will be covered in the first 45 minutes, leaving the second 45 minutes for Q\&A with the expert. This session provides the basic health information relevant to people with epilepsy, communication of which is often sacrificed in overcrowded clinics found in low resource settings.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Literacy Educational Session
Description: The Intervention is a 90 minute small group (n=6-10) session with an expert epilepsy provider reviewing fundamental information about epilepsy being a treatable neurologic condition, with topics including epidemiology, causation facts and myths, treatment and the importance of consistent medication, stigma, barriers to care and well-being. These topics will be covered in the first 45 minutes, leaving the second 45 minutes for Q\&A with the expert. This session provides the basic health information relevant to people with epilepsy, communication of which is often sacrificed in overcrowded clinics found in low resource settings.
Study: NCT04632784

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Artiflex Presbyopic implantation
Description: Implantation of iris-fixated multifocal Artiflex Presbyopic IOL
Study: NCT05397613

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: STAIR
Description: Clinician led session that hones in on a particular deficit within these skills, including identifying and labeling emotions, managing emotions, tolerating distress, accepting feelings and increasing positive emotions, identifying trauma-based interpersonal schemas, identifying conflict between trauma-related feelings and goals, role plays surrounding issues of power and control, and role-plays related to developing flexibility in interpersonal situations involving power differentials. STAIR is a cognitive-behavioral treatment that addresses emotion regulation and interpersonal difficulties and their impact on daily living.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: STAIR
Description: Clinician led session that hones in on a particular deficit within these skills, including identifying and labeling emotions, managing emotions, tolerating distress, accepting feelings and increasing positive emotions, identifying trauma-based interpersonal schemas, identifying conflict between trauma-related feelings and goals, role plays surrounding issues of power and control, and role-plays related to developing flexibility in interpersonal situations involving power differentials. STAIR is a cognitive-behavioral treatment that addresses emotion regulation and interpersonal difficulties and their impact on daily living.
Study: NCT06489379

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: high flow nasal cannula
Description: humidified and heated oxygen

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: standard oxygen
Description: oxygen delivery through Venturi mask
Study: NCT06445166

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propranolol Hydrochloride
Description: Dosing is as follows:~* Patients who weigh 40 to 59 kg:~  * 40 mg BID (target)~ * 20 mg BID (half the target)~* Patients who weigh ≥ 60 kg:~  * 60 mg BID (target)~ * 30 mg BID (half the target)
Study: NCT06180395

Intervention type: OTHER
Intervention: Group 1
Description: consisted of 37 children with CP classified to level I, II and III according to GMFCS., then:~Dual-energy X-ray absorptiometry (DXA) scans will be used to assess bone mineral density (BMD).~Gross motor function measurement scale (GMFM) will be used to assess gross motor function.~Quality of Life Questionnaire for Children (CP QOL-Child) will be used to assess quality of life (QOL).

Intervention type: OTHER
Intervention: Group 2
Description: consisted of 38 children with CP classified to level IV and V according to GMFCS. then:~Dual-energy X-ray absorptiometry (DXA) scans will be used to assess bone mineral density (BMD).~Gross motor function measurement scale (GMFM) will be used to assess gross motor function.~Quality of Life Questionnaire for Children (CP QOL-Child) will be used to assess quality of life (QOL).
Study: NCT06063590

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: StromaForte
Description: 100 millions allogeneic bone marrow (BM)-derived Mesenchymal Stromal Cell (MSC) formulated in sodium chloride supplemented with human serum albumin to be given via slow intravenous infusion in approximately 30 min
Study: NCT04691492

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Friend-Based Motivational Interview
Description: The intervention will use Motivational Interviewing's (MI) collaborative conversation style for strengthening commitment to change, to motivate and prepare women to work together to reduce Sexual Assault (SA) risk. This intervention will target ways that the friend dyad may support, encourage, and share responsibility with one another in protecting against SA. The Friend-based MI (FMI) will then use the responsibility and relationship of friends as a framework to foster collaborative efforts to increase readiness and decrease barriers to helping behavior. As part of this, the FMI will focus on the identification and implementation of skills friends can use to help one another prevent sexual assault. FMI will include a focused discussion of the ways drinking may impede helping efforts. Moreover, the FMI will encourage women to identify personal, specific strategies for reducing the effects of alcohol on helping.
Study: NCT06471998

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium Chloride injection
Description: Patients will receive a localized subcutaneous injection of 0.9% sodium chloride over 10 sessions (1 session per week), combined with standard treatment including stage I and II analgesics and physiotherapy in line with the recommendations of the French National Authority for Health.~At each session, 250ml to 500ml of physiological serum will be injected subcutaneously using a Meso-Kit-Perfuser\* or injection octopus positioned by the nurse according to the injection points defined by the investigating physician during the inclusion visit, with a dermographic tracer for surgical use.
Study: NCT05397938

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JMT103
Description: JMT103, subcutaneous injection, once every 6 months (Q6M)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JMT103
Description: JMT103, subcutaneous injection, once every 6 months (Q6M)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Alendronate sodium
Description: Alendronate sodium tablet, once every week (QW)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: JMT103 placebo
Description: JMT103 placebo, subcutaneous injection, once every 6 months (Q6M)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alendronate sodium placebo
Description: Alendronate sodium tablet placebo, once every week (QW)
Study: NCT06343688

Intervention type: OTHER
Intervention: Assessment of Balance and Lower Extremity Gross Motor Function with and without DAFO
Description: Measurements will be conducted with the child's custom-made DAFO (Dynamic Ankle-Foot Orthosis) and barefoot.
Study: NCT05429944

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motor Relearning Program
Description: The exercise will be performed for approximately 30 minutes, 3 times a week for 6 weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Proprioceptive Neuromuscular Facilitation
Description: The techniques administered included Rhythmic Initiation, Slow Reversal and Agonistic Reversal.~The exercise will be performed for approximately 30 minutes, 3 times a week for 6 weeks.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Physical Therapy
Description: The exercise will be performed for approximately 30 minutes, 3 times a week for 6 weeks.
Study: NCT05852873

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nirmatrelvir/ritonavir
Description: Participants in the intervention arm will receive a standard 5-day treatment course Paxlovid (nirmatrelvir plus ritonavir) in addition to standard of care.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants in the control arm will receive a 5-day course of placebo tablets, with the same appearance and quantity, in addition to standard of care.
Study: NCT05723796

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: nasal endoscopy
Description: nasal endoscopy and mucosal biopsy
Study: NCT05729854

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: acupressure ( traditional and complementary medicine)
Description: Acupressure will be applied to the shoulders, hands and legs of the women in the experimental group by the researcher.
Study: NCT06040658

Intervention type: DIAGNOSTIC_TEST
Intervention: Frailty assessment
Description: Rockwood Clinical Frailty Scale

Intervention type: DIAGNOSTIC_TEST
Intervention: Frailty assessment
Description: Frail NonDisabled Questionnaire (FiND)

Intervention type: DIAGNOSTIC_TEST
Intervention: Frailty assessment
Description: Clinician's subjective 'end-of-bed' test

Intervention type: DIAGNOSTIC_TEST
Intervention: Frailty assessment
Description: Healthcare Improvement Scotland FRAIL Scale

Intervention type: DIAGNOSTIC_TEST
Intervention: Frailty assessment
Description: 11-item modified Frailty Index (mFI-11)
Study: NCT04541264

Intervention type: DIAGNOSTIC_TEST
Intervention: radiomic of chest CT
Description: radiomics as a quantitative imaging method for early detection, risk assessment, and treatment decisions for early predicting sepsis induced acute respiratory distress syndrome.

Intervention type: DIAGNOSTIC_TEST
Intervention: radiomic of chest CT
Description: radiomics as a quantitative imaging method for early detection, risk assessment, and treatment decisions for early predicting sepsis induced acute respiratory distress syndrome.

Intervention type: DIAGNOSTIC_TEST
Intervention: radiomic of chest CT
Description: radiomics as a quantitative imaging method for early detection, risk assessment, and treatment decisions for early predicting sepsis induced acute respiratory distress syndrome.
Study: NCT04908540

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Mini-screw Assissted Rapid Palatal Expansion
Description: Mini-screw assissted RPE will be the main intervention in the two comparative groups. In the control (group A) will be used with its conventional activation protocol. While in experimental (group B) will be used with ALT-RAMEC protocol.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Mini-screw Assissted Rapid Palatal Expansion
Description: Mini-screw assissted RPE will be the main intervention in the two comparative groups. In the control (group A) will be used with its conventional activation protocol. While in experimental (group B) will be used with ALT-RAMEC protocol.
Study: NCT05513131

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax；Azacitidine；Homoharringtonine
Description: A cycle every 28 days Treatment with Venetoclax 100mg d1，200mg d2，400mg d3\~d14； Azacitidine 75mg/m2/d，d1\~d7 Homoharringtonine 2mg/d d1\~d7
Study: NCT05468385

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vagus nerve stimulation via tragus
Description: The device will send stimulus intensity of around 0.5mA via tragus in the left ear (based on participants' subjective report), delivered with a pulse width of 0.5 ms at 25 Hz. Stimulation will be active for 30 seconds, followed by a break of 30 seconds.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham stimulation via earlobe
Description: The device will send stimulus intensity of around 0.5mA via the earlobe in the left ear (based on participants' subjective reports), delivered with a pulse width of 0.5 ms at 25 Hz. Stimulation will be active for 30 seconds, followed by a break of 30 seconds.
Study: NCT06447285

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: SensoDetect BERA technology
Description: All recruited participants are to be tested using SensoDetect's patented technology. All tests shall be performed in a quiet and darkened room. Participants will be asked to be comfortably seated in an armchair in a resting position (part 1 only). Surface electrodes will then be attached to the skin over the mastoid bones behind the left and right ear, with a ground electrode on one arm. Two reference electrodes will also be placed on the forehead. Before each test session, the procedure shall be fully explained to the test subject or parents.~The subjects will then be instructed to relax with their eyes closed and are permitted to fall asleep (with modifications in part 3). The test will require no active participation other than being subjected to sound stimulation. The subjects will be tested one at a time, and the duration of the testing procedure will be 15 min.

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: SensoDetect BERA technology
Description: All recruited participants are to be tested using SensoDetect's patented technology. All tests shall be performed in a quiet and darkened room. Participants will be asked to be comfortably seated in an armchair in a resting position (part 1 only). Surface electrodes will then be attached to the skin over the mastoid bones behind the left and right ear, with a ground electrode on one arm. Two reference electrodes will also be placed on the forehead. Before each test session, the procedure shall be fully explained to the test subject or parents.~The subjects will then be instructed to relax with their eyes closed and are permitted to fall asleep (with modifications in part 3). The test will require no active participation other than being subjected to sound stimulation. The subjects will be tested one at a time, and the duration of the testing procedure will be 15 min.
Study: NCT05397938

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alendronate sodium placebo
Description: Alendronate sodium tablet placebo, once every week (QW)
Study: NCT05382455

Intervention type: OTHER
Intervention: Delphi Questionnaire
Description: An invitation email, including a link to the survey, will be sent to the panel of experts in Ai in healthcare.~The Delphi questionnaire will be administered via Welphi.com. In the first survey, panel members will outline the AI reporting standards in systematic reviews and objectively identify critical aspects of reporting methodology and results.~In subsequent surveys, the expert panel will evaluate the modified criteria using a 1 to 5-point Likert scale with space provided for suggested edits and comments. Multiple rounds will be conducted until consensus is reached. After each round of Likert responses, the study team will calculate the agreement and distribution of responses. Likert responses will be dichotomized with positive values indicating agreement and neutral or negative values indicating disagreement.~For the questions that do not reach a consensus of more than 80% in the first round or need further explanation, additional rounds of the survey may be performed.
Study: NCT05831540

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Discussion
Description: Participate in focus group

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational Activity
Description: Undergo training to use CDS tool
Study: NCT04619862

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gabapentin
Description: See arm descriptions
Study: NCT05831540

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthcare Activity
Description: Utilize CDS tool

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey Administration
Description: Complete survey
Study: NCT06491576

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BGT-002
Description: taking the study drug orally
Study: NCT04619862

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: See arm descriptions
Study: NCT04827251

Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Coffee
Description: Participants will receive Nespresso coffee maker Essenza model. The coffee Nespresso blend voluto will be provided (caffeinated and decaffeinated). The patients will have to take four cups of espresso per day (three cups a day for patients aged 65 and over).
Study: NCT06491576

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: taking the placebo orally
Study: NCT05346640

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cionic Neural Sleeve
Description: Adaptive, functional electrical stimulation
Study: NCT06225037

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sedline EEG monitoring
Description: Propofol titrated according to the raw EEG and spectrogram, aiming to maintain sedation (alpha oscillations +/- slow oscillations) and preventing burst suppression, keeping the PSI greater than 25 where possible.